SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes inspection at Anuh Pharma’s Palghar facilities

07 Feb 2026 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Anuh Pharma’s manufacturing facilities located at Palghar, Maharashtra. The inspection was completed with no Form 483 observations issued. The successful outcome of the inspection reaffirms the Company’s continued adherence to global regulatory and quality compliance standards.

Anuh Pharma, established in 1960, is one of the largest manufacturers of Macrolides and Anti-TB products in India.

Anuh Pharma Share Price

79.70 -2.29 (-2.79%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×